Contact Us

For more information about Okogen or to discuss investment opportunities, please reach out directly.

United States

Okogen, Inc.
332 Encinitas Blvd. Suite 102
Encinitas, CA 92024 USA

Australia

Okogen Pty Ltd
31 Queen St, 9th Floor
Melbourne, VIC 3000 AUS

Email Us

info@okogen.com

Latest News & Press

View All News
Press Release

Okogen, Inc., Announces Initiation of Phase IIb Clinical Trial for Pink Eye (Acute Infectious Conjunctivitis)

October 31, 2023
Read More
Press Release

Okogen, Inc., Announces Ophthalmology Industry Veteran Joshua Moriarty as New Chief Executive Officer

March 8, 2022
Read More
Press Release

Safe, Effective and Dose Responsive Anti-Viral Activity of OKG-0301 in Patients with Acute Adenoviral Conjunctivitis–Phase 2 Interim Analysis Results from RUBY Clinical Trial

April 29, 2021
Read More

© 2023 Okogen, Inc. All Rights Reserved

United States

Okogen, Inc.
332 Encinitas Blvd. Suite 102
Encinitas, CA 92024, USA

Australia

Okogen Pty Ltd
Level 9, 31 Queen St
Melbourne, VIC 3000 AUS

Main Menu